F.D.A.’s Approval of a Drug for Autism Upends Review Process​

F.D.A.’s Approval of a Drug for Autism Upends Review Process​

F.D.A.’s Approval of a Drug for Autism Upends Review Process​

 The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients.  

Creator: The New York Times (NYTHealth)

Related Posts

Vaccination and Public Health: Protecting Generations
Vaccination and Public Health
LEED Certification Standards: Building for a Sustainable Future
LEED Certification Standards
Natural Compounds in Drug Development: New Medicine Frontiers
Natural Compounds in Drug Development

Most Recent

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts